CAR-NK cell therapy targeting CD19 and BCMA

· The Children's Hospital of Zhejiang University School of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAR-NK cell therapy targeting CD19 and BCMA, covering 2026-03-24 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA CAR-NK Cell Injection for the Treatment of Refractory Pediatric Rheumatic Diseases [EARLY_Phase 1]

See pricing